drugset / Trial / NCT03562884

Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy

NCT03562884

Phase 3 Completed 297 enrolled Ipsen
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose is to demonstrate that BLI800 is non-inferior, on overall colon cleansing, to Fortrans® (a reference colonic lavage in China) administered in adult subjects scheduled to undergo a colonoscopy for a routinely accepted diagnostic indication.

Timeline

Start
2018-07-01
Primary completion
2019-04-28
Completion
2019-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI800 Unknown Oral
Comparator PICOPREP Small molecule 3000 ml Oral
Comparator PICOPREP Small molecule 4000 ml Oral

Indications

No indication recorded.